Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DR26F6S5G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,333
Award facts
- Contract value 100% obligated
- $5,333.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,333.07 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on November 17, 2025, with completion expected by November 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the supply of pharmaceutical products and medical commodities to military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Trelegy Ellipta is a combination maintenance inhaler used in respiratory treatment, representing the type of specialty pharmaceutical products the company routinely delivers through its DLA contracts to support Defense Health Agency operations and other federal healthcare systems. This award demonstrates the company's ongoing role as a primary supplier within the DLA's pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DR26F6S5G?
SPE2DR26F6S5G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F6S5G worth?
The government has obligated $5,333 on SPE2DR26F6S5G.
Is contract SPE2DR26F6S5G an order under another contract?
Yes. SPE2DR26F6S5G is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6S5G competed?
The extent of competition for SPE2DR26F6S5G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award